Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma [clinicaltrials:NCT00078637]
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma [clinicaltrials:NCT00078637]
Bio2RDF identifier
NCT00078637
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00078637
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This is a first-in-man, ...... nant solid tumor or lymphoma.
brief title [clinicaltrials_vocabulary:brief-title]
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
completion date [clinicaltrials_vocabulary:completion-date]
2007-02-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2004-03-03T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-12-19T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00078637
official title [clinicaltrials_vocabulary:official-title]
Phase I and Pharmacokinetic St ...... on to Patients With Malignancy
org study id [clinicaltrials_vocabulary:org-study-id]
E7820-A001-102
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2006-08-01T00:00:00Z
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2004-01-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-12-01T00:00:00Z
identifier
clinicaltrials:NCT00078637
title
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
@en
type
label
Dosing and Safety Study of E78 ...... a [clinicaltrials:NCT00078637]
@en